Search

Beyond Medicine, Interviews / BY: David R. Richardson, MD January/February 2022
... grew up with. There was a great sense of community, great people. We have always had lovely neighbors. Where’s your ... they’re wrong, and their failures. There are a lot of type-A people and we want control. I would admit it; it just ... populations. Also the changing dynamics of our patient profiles in our population; we’ve got an aging population, ...
MDs To Be / BY: Alessandro Cau, BSc (Hons) November 2022
Background Four million people currently live with chronic kidney disease in Canada, ... cotransporter-2 inhibitor (SGLT2i), in patients with type 2 diabetes, empagliflozin use was unexpectedly found to ... factors such as patient comorbidities and side effect profiles as well as which SGLT2i have documented renal and ...